BioArctic winner of the Allbright Award 2020
Stockholm, October 15, 2020 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has been awarded the 2020 Allbright Award for its focused work with gender equality. The announcement was made on October 15 during Allbright's annual award ceremony in Stockholm. BioArctic is a Swedish research-based biopharmaceutical company focusing on disease-modifying treatments for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The company is listed on Nasdaq Stockholm Mid Cap and has previously been nominated as a finalist for the